(Press-News.org) Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.
The findings, reported recently in the Journal of Clinical Investigation, point toward potential drug targets and prognostic markers for prostate cancer.
"We are trying to understand the molecular genetics of prostate cancer: what are the genes that are altered in human prostate cancer, and very importantly, how do they lead to cancer when they are changed?" said Sarki Abdulkadir, M.D., Ph.D., associate professor of Pathology, Microbiology and Immunology and of Cancer Biology.
Abdulkadir's lab uses mouse models to probe the molecular pathways involved in prostate cancer.
Two separate projects in the lab unexpectedly came together for this study — one led by postdoctoral fellow Philip Anderson, Ph.D., and the other spearheaded by (then) graduate student Sydika McKissic, Ph.D.
Anderson was using genomic approaches to understand how loss of a tumor suppressor protein, called NKX3.1, promotes prostate cancer. NKX3.1 is a transcription factor, meaning that it binds to and regulates the expression of other genes, turning them "on" or "off."
"It is one of the genes most commonly deleted in human prostate cancer…and is lost very early," explained Abdulkadir.
Anderson isolated the NKX3.1 protein and identified a set of 9,817 genes that bind to the protein. Of that set, he identified 282 genes that are regulated by the protein – i.e., their expression was altered by loss of NKX3.1.
"So we took those genes...and asked 'what is interesting about these genes?'" said Abdulkadir.
Using bioinformatics tools, the investigators found a quarter of the NKX3.1-regulated genes are also bound by a "famous" oncogene called Myc (which, like NKX3.1, is also a transcription factor).
It was previously known that, as human prostate cancer progresses, NKX3.1 levels decrease and Myc levels increase. The research team's findings showed that these two proteins with opposing functions regulated a similar set of genes.
"What we showed in this paper is that actually in many instances, NKX binds and represses these genes while Myc binds and activates them," Abdulkadir said. "The way we think about it is this: Myc is the 'accelerator' and NKX3.1 is the 'brake' (on cancer growth)."
Meanwhile, McKissic was working to develop a mouse model of prostate cancer. However, mice lacking NKX3.1 alone developed early stage prostate cancer, but the disease would not progress. Abdulkadir suspected that another genetic "hit" or mutation was necessary to progress fully to prostate cancer and suspected that Myc was a good candidate for that second "hit" based on how commonly the gene is altered in human prostate cancer.
So McKissic developed a mouse model in which NKX3.1 was deleted and Myc was overexpressed in the specific prostate cells where cancer arises.
She showed that mice with this combination of genetic alterations did progress to advanced cancer — and that the same target genes identified in Anderson's project were dysregulated in the mouse model.
To determine clinical relevance, the researchers then analyzed genetic and clinical data from patients with prostate cancer. They found that expression of these target genes was associated with tumor relapse – specifically, that suppression of a subset of the target genes may predict relapse.
In addition to potential prognostic indicators of relapse, these "cross-regulated" genes may present therapeutic targets to halt progression of prostate cancer.
Future studies on the roles of the individual target genes could help reveal "which of these genes are bigger players than others for things like therapeutics," Abdulkadir said.
INFORMATION:
The research was supported by grants from the National Cancer Institute (CA094858, CA123484, CA148950, and CA126505) of the National Institute of Health and from the Department of Defense.
Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
2012-08-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
New Hampshire leads nation in percent tree cover
2012-08-06
SYRACUSE. N.Y, August 6, 2012 – Tree cover in the nation's Lower 48 states covers 659 million acres, more than one-third of the nation, according to a U.S. Forest Service study of national tree cover and impervious surfaces. New Hampshire leads the nation in percent tree cover (89 percent), followed by Maine (83 percent) and Vermont (82 percent). On the other end of the spectrum, North Dakota has the lowest percent tree cover (3 percent), followed by Nebraska (4 percent) and South Dakota (6 percent).
Using aerial photograph interpretation of circa 2005 imagery, U.S. ...
A new line of defense: Researchers find cattle vaccine works to reduce E. coli O157:H7
2012-08-06
MANHATTAN, KAN. -- A commercial vaccine for cattle can effectively reduce levels of E. coli by more than 50 percent, a Kansas State University study has found. The vaccine is also effective using two doses instead of the recommended three doses, which can help cut costs for the beef industry.
David Renter, associate professor of epidemiology, is the principal investigator on a project that researched the effectiveness of products used to prevent the shedding of E. coli O157:H7 in cattle. The research appears in a recent online version of the journal Vaccine and helps ...
New approaches needed for uncovering, identifying, and treating buried chemical warfare material
2012-08-06
WASHINGTON — The current approach for identifying and destroying buried chemical munitions and related chemical warfare materials uncovered during environmental remediation projects is neither reliable enough nor has the capability to efficiently tackle large-scale projects, says a new report from the National Research Council. An alternative or modified approach is needed to remediate the Redstone Arsenal and other such projects on active and former U.S. Department of Defense sites and ranges.
Additionally, the report recommends that the Office of the Secretary of Defense ...
Off-label drug use common, but patients may not know they're taking them, Mayo finds
2012-08-06
Aug. 6, 2012
ROCHESTER, Minn. -- Many people have probably heard of off-label drug use, but they may not know when that applies to prescriptions they are taking, a Mayo Clinic analysis found. Off-label drug use occurs when a physician prescribes medication to treat a condition before that use has been approved by the Food and Drug Administration. In a newly published article in Mayo Clinic Proceedings, researchers pose and answer 10 questions about off-label drug use.
"Since the Food and Drug Administration does not regulate the practice of medicine, off-label drug ...
Airborne technology helps manage elephants
2012-08-06
Washington, D.C. – For years, scientists have debated how big a role elephants play in toppling trees in South African savannas. Tree loss is a natural process, but it is increasing in some regions, with cascading effects on the habitat for many other species. Using high resolution 3-D mapping, Carnegie scientists have for the first time quantitatively determined tree losses across savannas of Kruger National Park. They found that elephants are the primary agents—their browsing habits knock trees over at a rate averaging 6 times higher than in areas inaccessible to them. ...
Empa X-ray expert 'decodes' diesel soot
2012-08-06
Soot particles are dangerous – there is nothing new in this knowledge. But what is it that makes fine particulates dangerous? Is it only diesel soot from vehicle engines? Does the danger also come from wood-burning stoves in holiday chalets? Or even from grease-laden fryer fumes from the restaurant around the corner? For a long time, these questions have been a hard nut for science to crack. Indeed, fine soot particles were collected in filters and their chemical components were analysed. Yet the question remained: what precisely is the source of the danger? Is it the soot ...
Press freedom leads to happiness, environmental quality, MU study finds
2012-08-06
COLUMBIA, Mo. — Freedom of the press is viewed by many as a cornerstone of democracy. But can it actually help improve people's lives and make them happy? Researchers at the University of Missouri have found that citizens of countries with press freedom tend to be much happier than citizens of countries without free presses. Edson Tandoc, Jr., a doctoral student in the MU School of Journalism, says that press freedom directly predicts life satisfaction across the world.
"We already know that having reliable, objective news sources can benefit democracy, but in this study, ...
Adalimumab is a promising therapy for children with Crohn's disease
2012-08-06
Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
Steroids are commonly used in Crohn's disease, but can stunt growth and delay puberty. Incidence of this disease, which causes intestinal inflammation, is on the rise in children.
This study is the largest double-blind study of an anti-TNF agent in children with Crohn's disease. It found that more than 80 ...
'Green biased' yellow fever swept through Irish Immigrants in 19th century US
2012-08-06
New research by University of Warwick historian Dr Tim Lockley has found why yellow fever had a green bias in 19th century fever outbreaks in the southern states of the US. Almost half of the 650 people killed by yellow fever in Savannah Georgia in 1854 were Irish immigrants.
Dr Tim Lockley's study is based on four sources: the burial records of Laurel Grove cemetery; the records of the city's Catholic cemetery; the minutes of Savannah's Board of Health; and published lists of the dead in the Savannah Morning News. These sources yielded the names of 650 people who died ...
Infants of overweight mothers grow more slowly
2012-08-06
Pregnant women who are overweight or obese can encounter a host of health complications. The added weight also appears to affect how their children grow and develop, at least initially.
In a new study published in the Journal of Pediatrics, a team led by a University of Iowa researcher compared the weight and height of babies born to overweight and obese mothers with those born to normal-weight mothers.
Contrary to expectations, babies of overweight/obese mothers gained less weight and grew less in length than babies of normal-weight women from just after birth to ...